無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

スマート吸入器市場:製品別(吸入器およびネブライザー、ドライパウダー吸入器、定量吸入器)、適応別(喘息、COPD)、エンドユーザー別(患者、研究開発)-世界の機会分析と業界予測

Smart Inhalers Market by Product (Inhalers and Nebulizers, Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)), Indication (Asthma and COPD), End User (Patients and R and D) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

発行 Allied Market Research 商品コード 374530
出版日 ページ情報 英文 202 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.47円で換算しております。
Back to Top
スマート吸入器市場:製品別(吸入器およびネブライザー、ドライパウダー吸入器、定量吸入器)、適応別(喘息、COPD)、エンドユーザー別(患者、研究開発)-世界の機会分析と業界予測 Smart Inhalers Market by Product (Inhalers and Nebulizers, Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)), Indication (Asthma and COPD), End User (Patients and R and D) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
出版日: 2016年09月01日 ページ情報: 英文 202 Pages
概要

当レポートでは、世界のスマート吸入器市場について調査し、市場の概要と予測、競合動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
  • ファイブフォース分析
  • 大手企業ポジショニング
  • 治験
  • 製品ポートフォリオ
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会

第4章 世界のスマート吸入器市場:製品別

  • 概要
  • 吸入器
  • ネブライザー

第5章 世界のスマート吸入器市場:適応別

  • 概要
  • 喘息
  • COPD

第6章 世界のスマート吸入器市場:エンドユーザー別

  • 概要
  • 患者
  • 研究開発

第7章 世界のスマート吸入器市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ

第8章 企業プロファイル

  • Adherium Limited
  • Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)
  • Propeller Health
  • Cohero Health, LLC
  • OPKO Health, Inc. (Inspiro Medical Ltd.)
  • GlaxoSmithKline plc
  • Novartis AG
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • Vectura Group plc

図表

図表

List of Tables

  • TABLE 1 CLINICAL TRIALS: SMART INHALERS
  • TABLE 2 SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO
  • TABLE 3 SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 4 SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO
  • TABLE 5 SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 6 SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 7 SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 8 INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO
  • TABLE 9 INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 10 INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO
  • TABLE 11 INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
  • TABLE 12 INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 13 INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
  • TABLE 14 INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 15 INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 16 INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 17 INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 18 INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 19 INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 20 DPIS: TYPES
  • TABLE 21 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
  • TABLE 22 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 23 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
  • TABLE 24 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 25 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 26 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 27 SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO
  • TABLE 28 SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 29 SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO
  • TABLE 30 SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 31 SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 32 SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 33 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
  • TABLE 34 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 35 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
  • TABLE 36 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 37 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 38 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 39 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
  • TABLE 40 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 41 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
  • TABLE 42 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 43 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 44 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 45 SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO
  • TABLE 46 SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 47 SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO
  • TABLE 48 SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 49 SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 50 SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 51 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
  • TABLE 52 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 53 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
  • TABLE 54 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 55 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 56 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 57 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
  • TABLE 58 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 59 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
  • TABLE 60 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 61 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 62 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 63 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
  • TABLE 64 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 65 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
  • TABLE 66 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 67 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 68 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 69 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO
  • TABLE 70 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 71 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO
  • TABLE 72 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 73 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 74 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 75 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO
  • TABLE 76 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 77 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO
  • TABLE 78 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 79 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 80 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 81 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO
  • TABLE 82 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 83 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO
  • TABLE 84 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 85 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 86 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 87 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), MODERATE SCENARIO
  • TABLE 88 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 89 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), RAPID SCENARIO
  • TABLE 90 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 91 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 92 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 93 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO
  • TABLE 94 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 95 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO
  • TABLE 96 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 97 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 98 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 99 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO
  • TABLE 100 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 101 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO
  • TABLE 102 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 103 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 104 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 105 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO
  • TABLE 106 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 107 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO
  • TABLE 108 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 109 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 110 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 111 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), MODERATE SCENARIO
  • TABLE 112 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 113 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), RAPID SCENARIO
  • TABLE 114 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 115 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 116 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 117 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO
  • TABLE 118 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 119 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO
  • TABLE 120 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 121 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 122 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 123 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO
  • TABLE 124 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 125 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO
  • TABLE 126 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 127 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 128 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 129 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO
  • TABLE 130 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 131 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO
  • TABLE 132 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 133 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 134 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 135 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), MODERATE SCENARIO
  • TABLE 136 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 137 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), RAPID SCENARIO
  • TABLE 138 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 139 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 140 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 141 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO
  • TABLE 142 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 143 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO
  • TABLE 144 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 145 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 146 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 147 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO
  • TABLE 148 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 149 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO
  • TABLE 150 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 151 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 152 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 153 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO
  • TABLE 154 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 155 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO
  • TABLE 156 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 157 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 158 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 159 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), MODERATE SCENARIO
  • TABLE 160 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), DIMINISHING SCENARIO
  • TABLE 161 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), RAPID SCENARIO
  • TABLE 162 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
  • TABLE 163 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
  • TABLE 164 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), RAPID SCENARIO
  • TABLE 165 ADHERIUM: COMPANY SNAPSHOT
  • TABLE 166 ADHERIUM: OPERATING SEGMENTS
  • TABLE 167 TEVA: COMPANY SNAPSHOT
  • TABLE 168 TEVA: OPERATING SEGMENTS
  • TABLE 169 PROPELLER HEALTH: COMPANY SNAPSHOT
  • TABLE 170 PROPELLER HEALTH: OPERATING SEGMENTS
  • TABLE 171 COHERO HEALTH: COMPANY SNAPSHOT
  • TABLE 172 COHERO HEALTH: OPERATING SEGMENTS
  • TABLE 173 OPKO HEALTH: COMPANY SNAPSHOT
  • TABLE 174 OPKO HEALTH: OPERATING SEGMENTS
  • TABLE 175 GSK: COMPANY SNAPSHOT
  • TABLE 176 GSK: OPERATING SEGMENTS
  • TABLE 177 NOVARTIS: COMPANY SNAPSHOT
  • TABLE 178 NOVARTIS: OPERATING SEGMENTS
  • TABLE 179 ASTRAZENECA: COMPANY SNAPSHOT
  • TABLE 180 ASTRAZENECA: OPERATING SEGMENTS
  • TABLE 181 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
  • TABLE 182 BOEHRINGER INGELHEIM: OPERATING SEMENTS
  • TABLE 183 VECTURA: COMPANY SNAPSHOT
  • TABLE 184 VECTURA: OPERATING SEGMENTS

List of Figures

  • FIG. 1 PRIMARY RESPONDENTS: % SPLIT
  • FIG. 2 SMART INHALERS MARKET: SEGMENTATION
  • FIG. 3 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION
  • FIG. 4 TOP WINNING STRATEGIES: NATURE & TYPE
  • FIG. 5 TYPES OF STRATEGIES DISTRIBUTION
  • FIG. 6 DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
  • FIG. 7 DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
  • FIG. 8 TOP INVESTMENT POCKETS: WORLD SMART INHALERS, BY REGION
  • FIG. 9 PORTERS FIVE FORCES ANALYSIS
  • FIG. 10 TOP PLAYER POSITIONING, 2015
  • FIG. 11 TOP IMPACTING FACTORS: SMART INHALERS MARKET, 20152022
  • FIG. 12 ASTHMA: MAJOR INFLUENCING FACTORS
  • FIG. 13 ASTHMA: ECONOMIC BURDEN
  • FIG. 14 GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD) CLASSIFICATION OF COPD
  • FIG. 15 COPD: MAJOR CAUSES
  • FIG. 16 U.S.: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 17 U.S.: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 18 CANADA: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 19 CANADA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 20 MEXICO: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 21 MEXICO: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 22 GERMANY: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 23 GERMANY: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 24 UK: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 25 UK: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 26 FRANCE: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 27 FRANCE: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 28 ITALY: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 29 ITALY: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 30 RUSSIA: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 31 RUSSIA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 32 REST OF EUROPE: MARKET SIZE AND FORECAST
  • FIG. 33 REST OF EUROPE: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 34 REST OF EUROPE: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 35 JAPAN: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 36 JAPAN: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 37 CHINA: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 38 CHINA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 39 INDIA: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 40 INDIA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 41 AUSTRALIA: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 42 AUSTRALIA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 43 REST OF ASIA-PACIFIC: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 44 REST OF ASIA-PACIFIC: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 45 BRAZIL: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 46 BRAZIL: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 47 TURKEY: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 48 TURKEY: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 49 SAUDI ARABIA: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 50 SAUDI ARABIA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 51 UAE: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 52 UAE: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 53 REST OF LAMEA: SMART INHALERS MARKET SIZE, 20142022 ($000)
  • FIG. 54 REST OF LAMEA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
  • FIG. 55 ADHERIUM: NET REVENUE, 20142015 ($MILLION)
  • FIG. 56 ADHERIUM: STRATEGY SHARE, 20152016 (%)
  • FIG. 57 TEVA: REVENUE, 20132015 ($MILLION)
  • FIG. 58 TEVA: REVENUE, BY PRODUCT TYPE, 2015 (%)
  • FIG. 59 PROPELLER HEALTH: STRATEGY SHARE, 20152016 (%)
  • FIG. 60 COHERO HEALTH: STRATEGY SHARE, 20142016 (%)
  • FIG. 61 OPKO HEALTH: REVENUE, 20132015 ($MILLION)
  • FIG. 62 OPKO HEALTH: REVENUE, BY SEGMENT, 2015 (%)
  • FIG. 63 OPKO HEALTH: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 64 OPKO HEALTH: STRATEGY SHARE, 20132014 (%)
  • FIG. 65 GSK: REVENUE, 20132015 ($MILLION)
  • FIG. 66 GSK: REVENUE, BY SEGMENT, 2015 (%)
  • FIG. 67 GSK: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 68 GSK: STRATEGY SHARE, 20132015 (%)
  • FIG. 69 NOVARTIS: REVENUE, 20132015 ($MILLION)
  • FIG. 70 NOVARTIS: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 71 NOVARTIS: REVENUE, BY SEGMENT, 2015 (%)
  • FIG. 72 NOVARTIS: STRATEGY SHARE, 20132015 (%)
  • FIG. 73 ASTRAZENECA: REVENUE, 20132015 ($MILLION)
  • FIG. 74 ASTRAZENECA: REVENUE, BY SEGMENT, 2015 (%)
  • FIG. 75 ASTRAZENECA: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 76 ASTRAZENECA: STRATEGY SHARE, 20142016 (%)
  • FIG. 77 BOEHRINGER INGELHEIM: REVENUE, 20132015 ($MILLION)
  • FIG. 78 BOEHRINGER INGELHEIM: REVENUE, BY SEGMENT, 2015 (%)
  • FIG. 79 BOEHRINGER INGELHEIM: REVENUE, BY GEOGRAPHY, 2015 (%)
  • FIG. 80 BOEHRINGER INGELHEIM: STRATEGY SHARE, 20142016 (%)
  • FIG. 81 VECTURA: REVENUE, 20132015 ($MILLION)
  • FIG. 82 VECTURA: REVENUE, BY GEOGRAPHY, 2015 (%)
目次
Product Code: LI 161715

Smart inhalers are clip-on sensors, also known as connected inhalers, which are attached to the traditional inhalers. They are used to track the medication, dosage, and time taken for each dose. Linked wirelessly to the cloud, smart inhalers are a part of "Internet of Things," thus providing correct use of the medication, improved adherence to the inhaler, and better health outcomes. Doctors and patients can easily benefit from the use of smart inhalers as they monitor the dosage and provide reminders at the time of the dose, which can be recorded for understanding the patient's daily routine.

The world smart inhalers market is analyzed under three different scenarios, namely, moderate growth, rapid growth, and diminishing growth. Under the moderate growth scenario, smart inhalers market is estimated to reach $191 million by 2022, growing at a CAGR of 63.3% during 2016 to 2022. Market growth is attributed to the rapid increase in the incidence of respiratory diseases, rise in air pollution, and growth in healthcare burden, due to higher cases of asthma and COPD. In addition, expected increase in adherence to smart inhalers is another major factor for the growth of smart inhalers market. However, limited availability of smart inhalers, high cost of asthma and COPD treatment, and resistance towards adoption of smart inhalers are expected to hinder the market growth.

The market is segmented on the basis of product, indication, end user, and geography. By product, it is segmented into inhalers and nebulizers. Inhalers dominates the market, which is further divided into dry powder inhalers (DPIs) and metered dose inhalers (MDIs). Based on indication, smart inhalers are bifurcated into asthma and COPD. On the basis of end user, it is divided into patients and R&D. In terms of geography, the market is analyzed into North America, Europe, Asia-Pacific, and LAMEA.

North America was the leading revenue-generating region, whereas Asia-Pacific is projected to grow at the highest CAGR of 65.3%, owing to rise in demand for smart inhalers and increase in COPD and asthma cases.

Companies have adopted product approval and clinical trials as their key development strategies. Increase in focus on clinical trials is mainly for the development of innovative technologies in the field of smart inhalers. In March 2016, Adherium received a product approval to sell its "SmartTurbo" and "SmartTouch" devices in Canada, thereby expanding its product portfolio.

Key players operating in the market include:

  • Adherium Limited
  • Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)
  • Propeller Health
  • Cohero Health, LLC
  • OPKO Health, Inc. (Inspiro Medical Ltd.)
  • GlaxoSmithKline plc
  • Novartis AG
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • Vectura Group plc

KEY BENEFITS FOR STAKEHOLDERS:

  • The report provides an in-depth analysis of the estimated revenues generated by smart inhalers as well as major geographies during the forecast period.
  • The report presents three different market scenarios for smart inhalers, both for value and volume, based on rapid growth, diminishing growth, and moderate growth scenarios.
  • Quantitative analysis of the current market and estimations from 2016 to 2022 is presented to help the manufacturers of smart inhalers to analyze the market.
  • Entire projections presented in the report highlight the market potential, both in terms of value and volume.
  • The report conducts extensive analysis of the market by closely following key product positioning and monitoring the top contenders within the market framework.

KEY MARKET SEGMENTS:

By Product

  • Inhalers
  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Nebulizers

By Indication

  • Asthma
  • COPD

By End User

  • Patients
  • R&D

By Geography

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of LAMEA

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1 Report Description
  • 1.2 Key Benefits
  • 1.3 Key Market Segments
  • 1.4 Research Methodology
    • 1.4.1 Secondary Research
    • 1.4.2 Primary Research
    • 1.4.3 Analyst Tools and Models

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW

  • 3.1 Market Definition and Scope
  • 3.2 Key Findings
    • 3.2.1 Top Winning Strategies
    • 3.2.2 Top Investment Pockets
  • 3.3 Porters Five Forces Analysis
    • 3.3.1 Bargaining Power of Suppliers
    • 3.3.2 Bargaining Power of Buyers
    • 3.3.3 Threat of Substitutes
    • 3.3.4 Threat of New Entrants
    • 3.3.5 Intensity of Competitive Rivalry
  • 3.4 Top Player Positioning, 2015
  • 3.5 Clinical Trials
  • 3.6 Product Portfolio
  • 3.7 Market Dynamics
    • 3.7.1 Drivers
      • 3.7.1.1 Global increase in air pollution
      • 3.7.1.2 Increase in population susceptible to indoor air pollutants
      • 3.7.1.3 Increasing prevalence of COPD and asthma globally
      • 3.7.1.4 Expected increase in adherence to smart inhalers
      • 3.7.1.5 Increasing collaboration between pharmaceutical companies and smart inhaler manufacturers
      • 3.7.1.6 Rising incidences of chronic conditions
    • 3.7.2 Restraints
      • 3.7.2.1 Misusing data and data privacy
      • 3.7.2.2 Availability of smart inhalers
      • 3.7.2.3 Overall high cost of asthma and COPD treatment
      • 3.7.2.4 Resistance towards adoption of smart inhalers
    • 3.7.3 Opportunities
      • 3.7.3.1 Increased focus towards advanced treatment protocols
      • 3.7.3.2 Significant unmet need in respiratory care
      • 3.7.3.3 Increased awareness to reduce healthcare costs
      • 3.7.3.4 Opportunities in emerging economies

CHAPTER 4 SMART INHALERS MARKET, BY PRODUCT, 2014-2022

  • 4.1 Overview
    • 4.1.1 Market Size and Forecast
  • 4.2 Inhalers
    • 4.2.1 Key Market Trends
    • 4.2.2 Growth Factors and Opportunities
    • 4.2.3 Market Size and Forecast
    • 4.2.4 Dry Powder Inhalers (DPIs)
    • 4.2.5 Metered Dose Inhalers (MDIs)
  • 4.3 Nebulizers
    • 4.3.1 Key Market Trends
    • 4.3.2 Growth Factors and Opportunities
    • 4.3.3 Market Size and Forecast

CHAPTER 5 SMART INHALERS MARKET, BY INDICATION, 2014-2022

  • 5.1 Overview
    • 5.1.1 Market Size and Forecast
  • 5.2 Asthma
    • 5.2.1 Market Size and Forecast
  • 5.3 COPD
    • 5.3.1 Market Size and Forecast

CHAPTER 6 SMART INHALERS MARKET, BY END USER, 2014-2022

  • 6.1 Overview
    • 6.1.1 Market Size and Forecast
  • 6.2 Patients
    • 6.2.1 Market Size and Forecast
  • 6.3 R&D
    • 6.3.1 Market Size and Forecast

CHAPTER 7 SMART INHALERS MARKET, BY GEOGRAPHY, 2014-2022

  • 7.1 Overview
    • 7.1.1 Market Size and Forecast
  • 7.2 North America
    • 7.2.1 Key Market Trends
    • 7.2.2 Growth Factors and Opportunities
    • 7.2.3 Market Size and Forecast
      • 7.2.3.1 U.S.: Market Size and Forecast
      • 7.2.3.2 Canada: Market Size and Forecast
      • 7.2.3.3 Mexico: Market Size and Forecast
  • 7.3 Europe
    • 7.3.1 Key Market Trends
    • 7.3.2 Growth Factors and Opportunities
    • 7.3.3 Market Size and Forecast
      • 7.3.3.1 Germany: Market Size and Forecast
      • 7.3.3.2 UK: Market Size and Forecast
      • 7.3.3.3 France: Market Size and Forecast
      • 7.3.3.4 Italy: Market Size and Forecast
      • 7.3.3.5 Russia: Market Size and Forecast
  • 7.4 Asia-Pacific
    • 7.4.1 Key Market Trends
    • 7.4.2 Growth Factors and Opportunities
    • 7.4.3 Market Size and Forecast
      • 7.4.3.1 Japan: Market Size and Forecast
      • 7.4.3.2 China: Market Size and Forecast
      • 7.4.3.3 India: Market Size and Forecast
      • 7.4.3.4 Australia: Market Size and Forecast
      • 7.4.3.5 Rest of Asia-Pacific: Market Size and Forecast
  • 7.5 LAMEA (Latin America, Middle East, and Africa)
    • 7.5.1 Key Market Trends
    • 7.5.2 Growth Factors and Opportunities
    • 7.5.3 Market Size and Forecast
      • 7.5.3.1 Brazil: Market Size and Forecast
      • 7.5.3.2 Turkey: Market Size and Forecast
      • 7.5.3.3 Saudi Arabia: Market Size and Forecast
      • 7.5.3.4 UAE: Market Size and Forecast
      • 7.5.3.5 Rest of Lamea: Market Size and Forecast

CHAPTER 8 COMPANY PROFILES

  • 8.1 Adherium Limited
    • 8.1.1 Company Overview
    • 8.1.2 Company Snapshot
    • 8.1.3 Operating Business Segments
    • 8.1.4 Business Performance
    • 8.1.5 Key Strategic Moves and Developments
  • 8.2 Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)
    • 8.2.1 Company Overview
    • 8.2.2 Company Snapshot
    • 8.2.3 Operating Business Segments
    • 8.2.4 Business Performance
    • 8.2.5 Key Strategic Moves and Developments
  • 8.3 Propeller Health
    • 8.3.1 Company Overview
    • 8.3.2 Company Snapshot
    • 8.3.3 Operating Business Segments
    • 8.3.4 Business Performance
    • 8.3.5 Key Strategic Moves and Developments
  • 8.4 Cohero Health, LLC
    • 8.4.1 Company Overview
    • 8.4.2 Company Snapshot
    • 8.4.3 Operating Business Segments
    • 8.4.4 Business Performance
    • 8.4.5 Key Strategic Moves and Developments
  • 8.5 OPKO Health, Inc. (Inspiro Medical Ltd.)
    • 8.5.1 Company Overview
    • 8.5.2 Company Snapshot
    • 8.5.3 Operating Business Segments
    • 8.5.4 Business Performance
    • 8.5.5 Key Strategic Moves and Developments
  • 8.6 GlaxoSmithKline plc
    • 8.6.1 Company Overview
    • 8.6.2 Operating Business Segments
    • 8.6.3 Business Performance
    • 8.6.4 Key Strategic Moves and Developments
  • 8.7 Novartis AG
    • 8.7.1 Company Overview
    • 8.7.2 Operating Business Segments
    • 8.7.3 Business Performance
    • 8.7.4 Key Strategic Moves and Developments
  • 8.8 AstraZeneca plc
    • 8.8.1 Company Overview
    • 8.8.2 Operating Business Segments
    • 8.8.3 Business Performance
    • 8.8.4 Key Strategic Moves and Developments
  • 8.9 Boehringer Ingelheim GmbH
    • 8.9.1 Company Overview
    • 8.9.2 Operating Business Segments
    • 8.9.3 Business Performance
    • 8.9.4 Key Strategic Moves and Developments
  • 8.10 Vectura Group plc
    • 8.10.1 Company Overview
    • 8.10.2 Company Snapshot
    • 8.10.3 Operating Business Segments
    • 8.10.4 Business Performance
    • 8.10.5 Key Strategic Moves and Developments
Back to Top